Anne Cauvet

789 total citations
19 papers, 499 citations indexed

About

Anne Cauvet is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Anne Cauvet has authored 19 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Anne Cauvet's work include Systemic Sclerosis and Related Diseases (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Mast cells and histamine (3 papers). Anne Cauvet is often cited by papers focused on Systemic Sclerosis and Related Diseases (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Mast cells and histamine (3 papers). Anne Cauvet collaborates with scholars based in France, Norway and Japan. Anne Cauvet's co-authors include Yannick Allanore, Jérôme Avouac, Sonia Pezet, Muriel Elhaï, Masataka Kuwana, Carole Nicco, Frédéric Batteux, Ly Tu, Christophe Guignabert and Øyvind Molberg and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Anne Cauvet

18 papers receiving 494 citations

Peers

Anne Cauvet

PRM

PFM

IMMUN

EPIDE

Michela Pinnelli Italy

Monika Migdalska‐Sęk Poland

Andrea Ottria Netherlands

Michele Giansanti Italy

Sho Sendo Japan

Uwe Schlichting Germany

Begoña Ubilla Spain

Caixia Li China

Michela Pinnelli Italy

Anne Cauvet

50 ×0.2

PRM

111 ×0.5

PFM

62 ×0.5

216 ×1.8

IMMUN

140 ×1.3

EPIDE

Citations per year, relative to Anne Cauvet Anne Cauvet (= 1×) peers Michela Pinnelli

Countries citing papers authored by Anne Cauvet

Since Specialization

Citations

This map shows the geographic impact of Anne Cauvet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cauvet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cauvet more than expected).

Fields of papers citing papers by Anne Cauvet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cauvet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cauvet. The network helps show where Anne Cauvet may publish in the future.

Co-authorship network of co-authors of Anne Cauvet

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Cauvet. A scholar is included among the top collaborators of Anne Cauvet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Cauvet. Anne Cauvet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Gonzalez, Virginie, et al.. (2025). Inflammatory and angiogenic serum profile of refractory rheumatoid arthritis. Scientific Reports. 15(1). 7159–7159. 1 indexed citations

Cauvet, Anne, et al.. (2024). Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis. Lara D. Veeken. 64(5). 2792–2801. 1 indexed citations

Cauvet, Anne, et al.. (2024). AB1163 TYPE 1 INTERFERON SIGNATURE IN SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases. 83. 1915–1915.

Avouac, Jérôme, Anne Cauvet, Morgane Boulch, et al.. (2023). Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis. Arthritis & Rheumatology. 76(2). 268–278. 15 indexed citations

Cauvet, Anne, Christophe Guignabert, Raphaël Thuillet, et al.. (2023). Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis. Arthritis Research & Therapy. 25(1). 167–167. 1 indexed citations

Avouac, Jérôme, Virginie Gonzalez, Anne Cauvet, et al.. (2023). Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment. Scientific Reports. 13(1). 14626–14626. 3 indexed citations

Cauvet, Anne, Christophe Guignabert, Raphaël Thuillet, et al.. (2022). Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models. Arthritis Research & Therapy. 24(1). 13–13. 15 indexed citations

Frantz, C., Anne Cauvet, Aurélie Durand, et al.. (2022). Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis. Arthritis & Rheumatology. 74(8). 1387–1398. 16 indexed citations

Riccardi, Antonella, Cécile Contin‐Bordes, Jérôme Avouac, et al.. (2021). Erosive arthritis autoantibodies in systemic sclerosis. Seminars in Arthritis and Rheumatism. 52. 151947–151947. 11 indexed citations

10.

Pezet, Sonia, Anne Cauvet, Julie Pires Da Silva, et al.. (2020). Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis. Annals of the Rheumatic Diseases. 79(7). 891–900. 19 indexed citations

11.

Avouac, Jérôme, Anne Cauvet, Yuichiro Shirai, et al.. (2020). Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease. PLoS ONE. 15(5). e0232978–e0232978. 38 indexed citations

12.

Avouac, Jérôme, Sonia Pezet, Virginie Gonzalez, et al.. (2019). Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis. Journal of Investigative Dermatology. 140(3). 593–601.e7. 22 indexed citations

13.

Elhaï, Muriel, Anna‐Maria Hoffmann‐Vold, Jérôme Avouac, et al.. (2019). Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease. Arthritis & Rheumatology. 71(6). 972–982. 101 indexed citations

14.

Boleto, Gonçalo, Christophe Guignabert, Sonia Pezet, et al.. (2018). T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis. Arthritis Research & Therapy. 20(1). 197–197. 37 indexed citations

15.

Kavian, Niloufar, Mohamed Jeljeli, Nathaniel Edward Bennett Saidu, et al.. (2018). The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma. Frontiers in Immunology. 9. 1896–1896. 79 indexed citations

16.

Avouac, Jérôme, Irena Konstantinova, Christophe Guignabert, et al.. (2017). Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension. Annals of the Rheumatic Diseases. 76(11). 1931–1940. 66 indexed citations

17.

Koumakis, Eugénie, Matthieu Bouaziz, Philippe Dieudé, et al.. (2017). A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.. PubMed. 34 Suppl 100(5). 43–48. 3 indexed citations

18.

Avouac, Jérôme, Christophe Guignabert, Anna‐Maria Hoffmann‐Vold, et al.. (2017). Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis. Arthritis & Rheumatology. 69(11). 2209–2221. 21 indexed citations

19.

Ponsoye, Matthieu, C. Frantz, Nadira Ruzehaji, et al.. (2016). Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis. Annals of the Rheumatic Diseases. 75(12). 2142–2149. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact